Xi’an-based med-tech firm TianLong Science and Technology Co., Ltd has reportedly entered into a supply agreement with hospitals in northern Thailand to provide molecular diagnostic products for the detection of hepatitis B and C viruses (HBV/HCV). The company has secured a 7-year supply agreement, which was reached in October 2022.…